Lipid Lowering Medication Flashcards

1
Q

LDL

A

Bad cholesterol
-mainly responsible for development of atherosclerosis

Brings cholesterol to the cells for utilization

*Deposits extra cholesterol into vascular tissues ->atherosclerosis

Most LDL removed by the liver
-Liver disease=problem

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

HDL

A

Good cholesterol

Removes excess cholesterol from the cells and brings them to liver to be excreted

Can also remove cholesterol from directly from artery walls

Stops atherogenic lipoproteins from oxidizing

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Medications Lowering LDL Levels

A
Statins 
Ezetimibe
Bile Acid Sequesterants 
PCSK9 Inhibitors 
Niacin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Medications Lowering Triglyceride Levels

A

Omega 3s
Niacin
Fibrin Acid Derivatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

High Intensity LDL Lowering Statins

A

Greater than or equal to 50%

Atorvastatin 40-80mg

Rosuvastatin 20-40mg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Moderate Intensity LDL Lowering Statin Medications

A

30-50%

Atorvastatin 10-20mg 
Rosuvastatin 5-10mg 
Simvastatin 20-40mg 
Pravastatin 40-80mg 
Lovastatin 40mg
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Adverse Effects Statins

A

Pregnancy Category X

Hepatic Dysfunction/Headache

Muscle Complications: Myalgia, Myopathy, Rhabdomyolysis
-women, order age, people with severe kidney dysfunction or liver issues(increased LFTs or abuse alcohol) higher risk of muscle problems

*switch to ROSUVASTATIN

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

STATINS DDIs

A

Atorvastatin, Lovastatin, Simvastatin : CYP3A4
-avoid grapefruit juice, protease inhibitors, antifungals, warfarin

Binding: Bile Acid Sequestrants and Calcium containing products

Simvastatin and Amlodipine
*max dose of simvastatin is 20mg when given with amlodipine

*rule of thumb: use ROSUVASTATIN if patient is taking multiple meds

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Bile Acid Sequestrants TARGET and MOA

A

TARGET: lower LDL

  • Not actually absorbed
  • bind to bile acid in GI tract to increase excretion
  • less bile acid in circulation
  • more cholesterol is utilized to create more bile acids
  • decreased LDL in circulation
  • not absorbed, will have no systemic side effects
  • given usually when a patient cannot have statin
  • LAST LINE FOR LDL LOWERING
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Bile Acid Sequestrants Generic Drugs

A

Cholestyramine -powder

Colestipol -powder

Colesevelam -tablets

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Bile Acid Sequestrants ADVERSE EFFECTS and INTERACTIONS

A

Adverse effects:

  • poorly tolerated
  • significant GI side effects: bloating, gas, constipation, abdominal pain
  • increased TGs

Interactions:

  • bind to many medications, make them ineffective
  • give medication 1 hour before or 4 hours after warfarin, levothroxine, digoxin, statins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Niacin TARGET and MOA

A

Targets: TG
-possibly can increase HDL and lower LDL

MOA:

  • decreases VLDL synthesis (LDL is a byproduct of VLDL synthesis)
  • reduces breakdown of HDL

Vitamin B3: available over the counter at low doses
-but we want patients to be prescribed because of the poor side effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Niacin ADVERSE EFFECTS and DDIs

A

Adverse effects:

  • flushing (pretreatment with aspirin or NSAID)
  • pruritis (itchiness)
  • increase using acid and/or glucose (not good for diabetes)
  • nausea
  • abdominal discomfort

Pregnancy Category X

DO NOT COMBINE WITH STATINS
-maybe use in statin intolerant patients

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Ezetimibe TARGET and MOA

A

Cholesterol absorption inhibitor

Target: LDL
-no effect on TG

MOA:

  • stops absorption of cholesterol in the intestines
  • less cholesterol=less chylomicrons=less serum LDL

Second Line Treatment after Statins
-often used in combo with statins

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Ezetimibe ADVERSE EFFECTS and DDIs

A

Adverse effects:

  • diarrhea
  • arthralgia
  • fatigue
  • in combo with statins- increased LFTs

Do NOT administer with Bile Acid Sequestrants

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Fibrin Acid Derivatives TARGETS and MOAS

A

Target: TGs

  • use in patients with TG >500
  • number 1 treatment for lowering TG levels

MOA:

  • agonist at PPAR-alpha receptors
  • decreased VLDL synthesis in liver
  • increase lipolysis
  • higher clearance of TGs
17
Q

Fibric Acid Derivatives Generic Drug Names

A

Gembfibrozil

Fenofibrate

18
Q

Fibric Acid Derivatives ADVERSE EFFECTS and DDIs

A

Adverse effects:

  • myopathy (especially when using with statins)
  • increased LFTs
  • nausea
  • GI upset
  • skin rash

DO NOT GIVE GEMFIBROZIL WITH SIMVASTATIN

  • contraindication
  • BUT can use other fibric acid derivatives with other statins
19
Q

Omega 3s TARGET and MOA

A

Target: TGs

MOA:

  • inhibition of TG secretion from the liver
  • promotes metabolism of TG
20
Q

Omega 3s Drug Names

A

Available OTC and RX
-OTC fish oil

RX:

  • Vascepa
  • Lovaza

OTC formulations can vary

  • must watch for this
  • patients with >500TGs need RX in capsule form rather than OTC
21
Q

Omega 3s ADVERSE EFFECTS

A

Fishy taste (can put in freezer to combat this)

Burping

Antiplatelet effect at very high doses

  • potential risk for bleeding
  • must stop before surgery especially if on statin and aspirin too
22
Q

PCSK9 Inhibitors TARGET and MOA

A

Target: LDL
-HUGE effect:can lower LDL up to 70%

MOA:

  • monoclonal antibodies that stop PCSKP proteins
  • PCSK9 proteins normally increase free LDL in system
  • these drugs allow for more LDL to be cleared from the blood

WORKS BEST for FAMILIAL HYPERCHOLESTEROLEMIA

  • but very expensive, so reserve for patients who fail other agents
  • ex: familial hypercholesterolemia patient not responding to statin
23
Q

PCSK0 Inhibitors Drug Agents

A

Alirocumab
Evolocumab

Injectible Only

24
Q

PCSK9 Inhibitors ADVERSE EFFECTS and DDIs

A

Adverse Effects

  • injection site reactions
  • non specific effects common with monoclonal antibodies (headache, arthralgia, myalgia, limb pain, fatigue

Drug Interactions

  • NONE that we know of
  • encourage use with statins